HEPATIC STEATOSIS AND LIVER TRANSPLANTATION CURRENT CLINICAL AND EXPERIMENTAL PERSPECTIVES
HEPATITIS B CORE ANTIBODY-POSITIVE LIVER RECIPIENTS AND HEPATITIS B REACTIVATION AFTER LIVER TRANSPLANTATION
FURTHER LESSONS FROM KNOCKOUT MAN
FEASIBILITY OF IMMUNOSUPPRESSION IN COMPOSITE TISSUE ALLOGRAFTS BY SYSTEMIC ADMINISTRATION OF CTLA4Ig
ROLE OF HYPOMAGNESEMIA IN CHRONIC CYCLOSPORINE NEPHROPATHY1
SP-A-ENRICHED SURFACTANT FOR TREATMENT OF RAT LUNG TRANSPLANTS WITH SP-A DEFICIENCY AFTER STORAGE AND REPERFUSION1
INHIBITORY EFFECTS OF IMMUNOSUPPRESSIVE DRUGS ON INSULIN SECRETION FROM HIT-T15 CELLS AND WISTAR RAT ISLETS1
EXPERIENCES WITH LEFLUNOMIDE IN SOLID ORGAN TRANSPLANTATION
PROTEINURIA AFTER INJECTION OF HUMAN FOCAL SEGMENTAL GLOMERULOSCLEROSIS FACTOR1 2
IMMUNOLOGICAL AND VIROLOGICAL EFFECTS OF RIBAVIRIN IN HEPATITIS C AFTER LIVER TRANSPLANTATION1
POSTTRANSPLANT DIABETES MELLITUS IN KIDNEY ALLOGRAFT RECIPIENTS: INCIDENCE, RISK FACTORS, AND MANAGEMENT1
Ki67, E-CADHERIN, AND p53 AS PROGNOSTIC INDICATORS OF LONG-TERM OUTCOME AFTER LIVER TRANSPLANTATION FOR METASTATIC NEUROENDOCRINE TUMORS
RECURRENCE OF NEPHROTIC SYNDROME IN KIDNEY GRAFTS OF PATIENTS WITH CONGENITAL NEPHROTIC SYNDROME OF THE FINNISH TYPE
ACUTE THROMBOSIS OF RENAL TRANSPLANT ARTERY
KIDNEY TRANSPLANTATION IN CHILDREN WEIGHING LESS THAN 15 kg: DONOR SELECTION AND TECHNICAL CONSIDERATIONS
ARTEROPORTAL FISTULAS BETWEEN THE ACCESSORY RIGHT HEPATIC, GASTRODUODENAL AND SUPERIOR MESENTERIC ARTERIES AND PORTAL VEIN: A DIFFICULT TECHNICAL PROBLEM TO OVERCOME IN LIVER TRANSPLANTATION
CLINICAL AND LABORATORY EVALUATION OF THE SAFETY OF A BIOARTIFICIAL LIVER ASSIST DEVICE FOR POTENTIAL TRANSMISSION OF PORCINE ENDOGENOUS RETROVIRUS
CD97-DECAY-ACCELERATING FACTOR INTERACTION IS NOT INVOLVED IN LEUKOCYTE ADHESION TO ENDOTHELIAL CELLS1
CD4+ T CELLS INITIATE PANCREATIC ISLET XENOGRAFT REJECTION VIA AN INTERFERON-γ-DEPENDENT RECRUITMENT OF MACROPHAGES AND NATURAL KILLER CELLS1
MODELING CHRONIC LUNG ALLOGRAFT REJECTION IN MINIATURE SWINE1
TREATMENT WITH ANTI-CD154 ANTIBODY AND DONOR-SPECIFIC TRANSFUSION PREVENTS ACUTE REJECTION OF MYOBLAST TRANSPLANTATION1
CELLULAR CARDIOMYOPLASTY IN A TRANSGENIC MOUSE MODEL
EPSTEIN-BARR VIRUS INFECTION IS ASSOCIATED WITH ENDOTHELIAL BCL-2 EXPRESSION IN TRANSPLANT LIVER ALLOGRAFTS
BENEFITS OF CHRONIC PLASMAPHERESIS AND INTRAVENOUS HEME-ALBUMIN IN ERYTHROPOIETIC PROTOPORPHYRIA AFTER ORTHOTOPIC LIVER TRANSPLANTATION1 2
SHORT COURSE INDUCTION IMMUNOSUPPRESSION WITH THYMOGLOBULIN FOR RENAL TRANSPLANT RECIPIENTS1
SUCCESSFUL TREATMENT OF MUCOR INFECTION AFTER LIVER OR PANCREAS-KIDNEY TRANSPLANTATION
FAILURE OF REACTIVATION OF HEPATITIS B AFTER LIVER TRANSPLANTATION IN HEPATITIS B SURFACE ANTIGEN-NEGATIVE, CORE ANTIBODY-POSITIVE RECIPIENTS
ISOLATED XENO AND ISOPERFUSED RAT LIVER: EXPERIMENTAL PROCEDURE AND RESULTS
ISOLATED XENO AND ISOPERFUSED RAT LIVER: EXPERIMENTAL PROCEDURE AND RESULTS
ANNOUNCEMENTS